Patents Assigned to KAMEDIS LTD.
  • Patent number: 11938190
    Abstract: Disclosed is a formulation comprising at least two of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts or prevalent molecules therefrom and a pharmaceutically acceptable carrier. Further disclosed is a formulation comprising one or more of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts, or prevalent molecules therefrom in combination with acyclovir and a pharmaceutically acceptable carrier. Disclosed also is a method for treating herpesvirus infections by administering a formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum or Sanguisorba officinalis extracts or prevalent molecules therefrom with or without an antiviral agent, such as acyclovir and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 30, 2018
    Date of Patent: March 26, 2024
    Assignee: KAMEDIS LTD
    Inventors: Yonit Bomstein, Jonathan Marder, Tali Pechenick Jowers
  • Patent number: 11478522
    Abstract: Disclosed is a topical formulation comprising the herbal extracts Portulaca oleracea extract, Rheum palmatum root extract, Chrysanthemum indicum flower extract, Scutellaria baicalensis root extract Phellodendron amurense bark extract and Sanguisorba officinalis root extract or their active molecules. Disclosed also is a topical formulation comprising Portulaca oleracea extract, Rheum palmatum root extract, Chrysanthemum indicum flower extract, Scutellaria baicalensis root extract and Phellodendron amurense bark extract or their active molecules. Further disclosed are methods of treating or preventing acne, comprising administering the disclosed formulations.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: October 25, 2022
    Assignee: KAMEDIS LTD
    Inventors: Yonit Bomstein, Jonathan Marder
  • Patent number: 10967031
    Abstract: Disclosed is a method of treating and/or preventing atopic dermatitis (AD) in a subject in need thereof, wherein the method comprises administering to the subject a therapeutically effective amount of a composition comprising a Sanguisorba officinalis root extract, an Ailanthus altissima bark extract, a Rheum palmatum root extract, a Cnidium monnieri fruit extract, a Scutellaria baicalensis root extract, and Glycyrrhiza glabra root extract thereby treating and/or preventing AD in the subject.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: April 6, 2021
    Assignee: KAMEDIS LTD.
    Inventors: Sharon Rozenblat, Yonit Bomstein, Jonathan Marder
  • Publication number: 20200397908
    Abstract: Disclosed is a formulation comprising at least two of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts or prevalent molecules therefrom and a pharmaceutically acceptable carrier. Further disclosed is a formulation comprising one or more of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts, or prevalent molecules therefrom in combination with acyclovir and a pharmaceutically acceptable carrier. Disclosed also is a method for treating herpesvirus infections by administering a formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum or Sanguisorba officinalis extracts or prevalent molecules therefrom with or without an antiviral agent, such as acyclovir and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 30, 2018
    Publication date: December 24, 2020
    Applicant: KAMEDIS LTD
    Inventors: Yonit BOMSTEIN, Jonathan MARDER, Tali PECHENICK JOWERS
  • Publication number: 20190269747
    Abstract: Disclosed is a topical formulation comprising the herbal extracts Portulaca oleracea extract, Rheum palmatum root extract, Chrysanthemum indicum flower extract, Scutellaria baicalensis root extract Phellodendron amurense bark extract and Sanguisorba officinalis root extract or their active molecules. Disclosed also is a topical formulation comprising Portulaca oleracea extract, Rheum palmatum root extract, Chrysanthemum indicum flower extract, Scutellaria baicalensis root extract and Phellodendron amurense bark extract or their active molecules. Further disclosed are methods of treating or preventing acne, comprising administering the disclosed formulations.
    Type: Application
    Filed: November 13, 2017
    Publication date: September 5, 2019
    Applicant: KAMEDIS LTD.
    Inventors: Yonit BOMSTEIN, Jonathan MARDER
  • Patent number: 10226499
    Abstract: A composition comprising a Sanguisorbae officinalis plant extract and at least one additional plant extract selected from the group consisting of an Ailanthus altissima plant extract, a Galla rhois gallnut plant extract, a Glycyrrhiza Glabra plant extract, a Rheum palmatum plant extract and a Scutellaria baicalensis plant extract is disclosed. Compositions comprising Ailanthus altissima plant extract or Ailanthone are also disclosed.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: March 12, 2019
    Assignees: KAMEDIS LTD., BIO-FD&C CO. LTD.
    Inventors: Sharon Rozenblat, DaiHyun Jung, SangHyun Moh, SuJung Kim, JungHun Lee
  • Publication number: 20180169171
    Abstract: Disclosed is a method of treating and/or preventing atopic dermatitis (AD) in a subject in need thereof, wherein the method comprises administering to the subject a therapeutically effective amount of a composition comprising a Sanguisorba officinalis root extract, an Ailanthus altissima bark extract, a Rheum palmatum root extract, a Cnidium monnieri fruit extract, a Scutellaria baicalensis root extract, and Glycyrrhiza glabra root extract thereby treating and/or preventing AD in the subject.
    Type: Application
    Filed: February 20, 2018
    Publication date: June 21, 2018
    Applicant: KAMEDIS LTD.
    Inventors: Yonit BOMSTEIN, Jonathan Marder